Expert review of medical devices · 2025
An overview of the t:slim X2 and Mobi insulin pumps with Control-IQ technology: patient safety and device efficacy.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sawyer Alexandra, Forlenza Gregory P, Wadwa R Paul
Аннотация
INTRODUCTION: Type 1 diabetes is a chronic disease requiring lifelong intensive insulin treatment. Automated insulin delivery (AID) systems such as Tandem Control-IQ allow for automatic adjustment of insulin delivery and can help improve glycemic outcomes.
AREAS COVERED: This review will cover Tandem Control IQ AID technology and the Tandem t:slim X2 and Tandem Mobi insulin pumps including their physical features and function, the algorithm guiding insulin delivery, research regarding their safety and efficacy, and a brief overview of other AID systems. References were identified using PubMed.
EXPERT OPINION: AID is now being considered as the standard for management of type 1 diabetes. Tandem Control IQ technology is one of several systems currently available that allows the user to benefit from the latest diabetes technology. Optimizing use of this system can lead to improved glycemic outcomes and decreased burden of disease for people with diabetes compared to multiple daily injections or open-loop insulin pump therapy.
AREAS COVERED: This review will cover Tandem Control IQ AID technology and the Tandem t:slim X2 and Tandem Mobi insulin pumps including their physical features and function, the algorithm guiding insulin delivery, research regarding their safety and efficacy, and a brief overview of other AID systems. References were identified using PubMed.
EXPERT OPINION: AID is now being considered as the standard for management of type 1 diabetes. Tandem Control IQ technology is one of several systems currently available that allows the user to benefit from the latest diabetes technology. Optimizing use of this system can lead to improved glycemic outcomes and decreased burden of disease for people with diabetes compared to multiple daily injections or open-loop insulin pump therapy.